Meanwhile, in the research field of inflammatory bowel disease (IBD), clinical cohort analyses have found a significant positive correlation between the serum concentration of the enteric nervous system glial cell-specific marker S100β and fecal calprotectin levels [67], providing a new approach for non-invasive monitoring of the degree of ENS damage. Here, S100B is linked to inflammatory bowel disease.